{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:47:15Z","timestamp":1782182835168,"version":"3.54.5"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China"},{"name":"Prevention and Control of Emerging and Major Infectious Diseases National Science and Technology Major Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sepsis disproportionately affects older adults and children, two immunologically vulnerable extremes of age. Yet sepsis is superimposed on distinct baselines\u2014immunosenescence in the elderly and immune immaturity in neonates and young children\u2014leading to different pathways toward immune failure. This comparative narrative review synthesizes clinical and experimental evidence on age-specific and shared alterations in lymphocyte subsets in sepsis, including lymphopenia; CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell activation, apoptosis, and exhaustion; B cell depletion and impaired antibody production; NK cell cytotoxic defects; and dynamic regulatory circuits such as Tregs. Recognizing that early organ injury is initiated and amplified primarily by innate immune programs, we frame lymphocyte injury largely as a downstream cost of the acute host-response milieu that can become rate-limiting for immune recovery, secondary infections, and late mortality. We highlight convergent phenotypes linked to secondary infections and late mortality, while emphasizing differences in kinetics, mechanisms, and recovery potential. We propose an age-stratified approach to serial immune monitoring and biomarker-enriched trial design to guide immunoadjuvant therapies and avoid one-size-fits-all immunomodulation. Clarifying these trajectories may improve risk stratification and outcomes across the lifespan.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08773-3","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:36:00Z","timestamp":1777970160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-related differences and common pathways of lymphocyte subsets in sepsis: a comparative review of elderly and pediatric patients"],"prefix":"10.1038","volume":"17","author":[{"given":"Xianwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-7840","authenticated-orcid":false,"given":"Zhaoxin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"8773_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311.","journal-title":"Lancet"},{"key":"8773_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/epidemiologia5030032","volume":"5","author":"L La Via","year":"2024","unstructured":"La Via L, Sangiorgio G, Stefani S, Marino A, Nunnari G, Cocuzza S, et al. The Global Burden of Sepsis and Septic Shock. Epidemiologia. 2024;5:456\u201378.","journal-title":"Epidemiologia"},{"key":"8773_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","volume":"6","author":"C Fleischmann-Struzek","year":"2018","unstructured":"Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6:223\u201330.","journal-title":"Lancet Respir Med"},{"key":"8773_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/archdischild-2020-320217","volume":"106","author":"C Fleischmann","year":"2021","unstructured":"Fleischmann C, Reichert F, Cassini A, Horner R, Harder T, Markwart R, et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child. 2021;106:745\u201352.","journal-title":"Arch Dis Child"},{"key":"8773_CR5","volume":"16","author":"AH Alhamyani","year":"2024","unstructured":"Alhamyani AH, Alamri MS, Aljuaid NW, Aloubthani AH, Alzahrani S, Alghamdi AA, et al. Sepsis in aging populations: a review of risk factors, diagnosis, and management. Cureus. 2024;16:e74973.","journal-title":"Cureus"},{"key":"8773_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fmed.2017.00020","volume":"4","author":"S Mart\u00edn","year":"2017","unstructured":"Mart\u00edn S, P\u00e9rez A, Aldecoa C. Sepsis and immunosenescence in the elderly patient: a review. Front Med. 2017;4:20.","journal-title":"Front Med"},{"key":"8773_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01233-7","volume":"14","author":"M Ibarz","year":"2024","unstructured":"Ibarz M, Haas LEM, Ceccato A, Artigas A. The critically ill older patient with sepsis: a narrative review. Ann Intensive Care. 2024;14:6.","journal-title":"Ann Intensive Care"},{"key":"8773_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407\u201320.","journal-title":"Nat Rev Immunol"},{"key":"8773_CR9","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54:2450\u201364.","journal-title":"Immunity"},{"key":"8773_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862\u201374.","journal-title":"Nat Rev Immunol"},{"key":"8773_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2017","unstructured":"Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2017;14:121\u201337.","journal-title":"Nat Rev Nephrol"},{"key":"8773_CR12","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594\u2013605.","journal-title":"JAMA"},{"key":"8773_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1110070","volume":"14","author":"Q Li","year":"2023","unstructured":"Li Q, Sun M, Zhou Q, Li Y, Xu J, Fan H. Integrated analysis of multi-omics data reveals T cell exhaustion in sepsis. Front Immunol. 2023;14:1110070.","journal-title":"Front Immunol"},{"key":"8773_CR14","first-page":"20143085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282:20143085.","journal-title":"Proc Biol Sci"},{"key":"8773_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576\u201390.","journal-title":"Nat Rev Endocrinol"},{"key":"8773_CR16","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","volume":"8","author":"T Fulop","year":"2018","unstructured":"Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol. 2018;8:1960.","journal-title":"Front Immunol"},{"key":"8773_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.942796","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Dong C, Han Y, Gu Z, Sun C. Immunosenescence, aging and successful aging. Front Immunol. 2022;13:942796.","journal-title":"Front Immunol"},{"key":"8773_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fped.2020.00005","volume":"8","author":"GP Tsafaras","year":"2020","unstructured":"Tsafaras GP, Ntontsi P, Xanthou G. Advantages and limitations of the neonatal immune system. Front Pediatr. 2020;8:5.","journal-title":"Front Pediatr"},{"key":"8773_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00281-017-0657-6","volume":"39","author":"TR Kollmann","year":"2017","unstructured":"Kollmann TR, Marchant A. Immunity and immunopathology in early human life. Semin Immunopathol. 2017;39:575\u20136.","journal-title":"Semin Immunopathol"},{"key":"8773_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.molmed.2016.02.001","volume":"22","author":"B Kan","year":"2016","unstructured":"Kan B, Razzaghian HR, Lavoie PM. An immunological perspective on neonatal sepsis. Trends Mol Med. 2016;22:290\u2013302.","journal-title":"Trends Mol Med"},{"key":"8773_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:762\u201374.","journal-title":"JAMA"},{"key":"8773_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest. 2016;126:23\u201331.","journal-title":"J Clin Invest"},{"key":"8773_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13:260\u20138.","journal-title":"Lancet Infect Dis"},{"key":"8773_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05099-4","volume":"28","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhang W, Chen L, Lu X, Tu Y. Lymphopenia in sepsis: a narrative review. Crit Care. 2024;28:315.","journal-title":"Crit Care"},{"key":"8773_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","volume":"42","author":"AM Drewry","year":"2014","unstructured":"Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014;42:383\u201391.","journal-title":"Shock"},{"key":"8773_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"EE Davenport","year":"2016","unstructured":"Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4:259\u201371.","journal-title":"Lancet Respir Med"},{"key":"8773_CR27","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, et al. Transcriptomic signatures in sepsis and a differential response to steroids. from the VANISH randomized trial. Am J Respir Crit Care Med. 2019;199:980\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"8773_CR28","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","volume":"166","author":"RS Hotchkiss","year":"2001","unstructured":"Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE, Hui JJ, Chang KC, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol. 2001;166:6952\u201363.","journal-title":"J Immunol"},{"key":"8773_CR29","doi-asserted-by":"crossref","unstructured":"Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018;3:e98960.","DOI":"10.1172\/jci.insight.98960"},{"key":"8773_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.2008.697","volume":"300","author":"AP Limaye","year":"2008","unstructured":"Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413\u201322.","journal-title":"JAMA"},{"key":"8773_CR31","doi-asserted-by":"publisher","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","volume":"9","author":"AH Walton","year":"2014","unstructured":"Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, et al. Reactivation of multiple viruses in patients with sepsis. PLoS One. 2014;9:e98819.","journal-title":"PLoS One"},{"key":"8773_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1811-9","volume":"17","author":"M Xue","year":"2019","unstructured":"Xue M, Xie J, Liu L, Huang Y, Guo F, Xu J, et al. Early and dynamic alterations of Th2\/Th1 in previously immunocompetent patients with community-acquired severe sepsis: a prospective observational study. J Transl Med. 2019;17:57.","journal-title":"J Transl Med"},{"key":"8773_CR33","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/CCM.0000000000005047","volume":"49","author":"D Guinault","year":"2021","unstructured":"Guinault D, Nicolau-Travers M-L, Silva S, Cointault O, Daniau B, Del Bello A, et al. Expression of exhaustion markers on CD8+ T-cell patterns predict outcomes in septic patients admitted to the ICU. Crit Care Med. 2021;49:1513\u201323.","journal-title":"Crit Care Med"},{"key":"8773_CR34","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2147\/IJGM.S402586","volume":"16","author":"L Wang","year":"2023","unstructured":"Wang L, Zhang Z, Chen X, Yu F, Huang H, Shen X, et al. Relationship between the expression of PD-1 and CTLA-4 on T lymphocytes and the severity and prognosis of sepsis. Int J Gen Med. 2023;16:1513\u201325.","journal-title":"Int J Gen Med"},{"key":"8773_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1632902","volume":"2018","author":"Q Xia","year":"2018","unstructured":"Xia Q, Wei L, Zhang Y, Sheng J, Wu W, Zhang Y. Immune checkpoint receptors Tim-3 and PD-1 regulate monocyte and T lymphocyte function in septic patients. Mediators Inflamm. 2018;2018:1632902.","journal-title":"Mediators Inflamm"},{"key":"8773_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/infdis\/jiaa191","volume":"222","author":"J-S Lou","year":"2020","unstructured":"Lou J-S, Wang J-F, Fei M-M, Zhang Y, Wang J, Guo Y, et al. Targeting lymphocyte activation gene 3 to reverse T-lymphocyte dysfunction and improve survival in murine polymicrobial sepsis. J Infect Dis. 2020;222:1051\u201361.","journal-title":"J Infect Dis"},{"key":"8773_CR37","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00134-019-05704-z","volume":"45","author":"RS Hotchkiss","year":"2019","unstructured":"Hotchkiss RS, Colston E, Yende S, Crouser ED, Martin GS, Albertson T, et al. Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab. Intensive Care Med. 2019;45:1360\u201371.","journal-title":"Intensive Care Med"},{"key":"8773_CR38","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/CCM.0000000000003685","volume":"47","author":"RS Hotchkiss","year":"2019","unstructured":"Hotchkiss RS, Colston E, Yende S, Angus DC, Moldawer LL, Crouser ED, et al. Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559). Crit Care Med. 2019;47:632\u201342.","journal-title":"Crit Care Med"},{"key":"8773_CR39","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00134-008-1337-8","volume":"35","author":"F Venet","year":"2008","unstructured":"Venet F, Chung C-S, Kherouf H, Geeraert A, Malcus C, Poitevin F, et al. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 2008;35:678\u201386.","journal-title":"Intensive Care Med"},{"key":"8773_CR40","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/CCM.0000000000002380","volume":"45","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Fear D, Lavender P, Mare T, Beale R, Swanson C, et al. Activation-associated accelerated apoptosis of memory B cells in critically ill patients with sepsis. Crit Care Med. 2017;45:875\u201382.","journal-title":"Crit Care Med"},{"key":"8773_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1034667","volume":"13","author":"C Ma","year":"2022","unstructured":"Ma C, Liu H, Yang S, Li H, Liao X, Kang Y. The emerging roles and therapeutic potential of B cells in sepsis. Front Pharm. 2022;13:1034667.","journal-title":"Front Pharm"},{"key":"8773_CR42","doi-asserted-by":"publisher","first-page":"e50446","DOI":"10.1371\/journal.pone.0050446","volume":"7","author":"J-M Forel","year":"2012","unstructured":"Forel J-M, Chiche L, Thomas G, Mancini J, Farnarier C, Cognet C, et al. Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS One. 2012;7:e50446.","journal-title":"PLoS One"},{"key":"8773_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/JLB.4A0818-313RR","volume":"107","author":"T Feng","year":"2019","unstructured":"Feng T, Liao X, Yang X, Yang C, Lin F, Guo Y, et al. A shift toward inhibitory receptors and impaired effector functions on NK cells contribute to immunosuppression during sepsis. J Leukoc Biol. 2019;107:57\u201367.","journal-title":"J Leukoc Biol"},{"key":"8773_CR44","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.idc.2017.07.010","volume":"31","author":"TA Rowe","year":"2017","unstructured":"Rowe TA, McKoy JM. Sepsis in older adults. Infect Dis Clin North Am. 2017;31:731\u201342.","journal-title":"Infect Dis Clin North Am"},{"key":"8773_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12979-020-0173-8","volume":"17","author":"R Thomas","year":"2020","unstructured":"Thomas R, Wang W, Su D-M. Contributions of age-related thymic involution to immunosenescence and inflammaging. Immun Ageing. 2020;17:2.","journal-title":"Immun Ageing"},{"key":"8773_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13671","volume":"21","author":"Z Liang","year":"2022","unstructured":"Liang Z, Dong X, Zhang Z, Zhang Q, Zhao Y. Age-related thymic involution: mechanisms and functional impact. Aging Cell. 2022;21:e13671.","journal-title":"Aging Cell"},{"key":"8773_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3324\/haematol.2018.211334","volume":"105","author":"Y-H Ho","year":"2019","unstructured":"Ho Y-H, M\u00e9ndez-Ferrer S. Microenvironmental contributions to hematopoietic stem cell aging. Haematologica. 2019;105:38\u201346.","journal-title":"Haematologica"},{"key":"8773_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-\u017dugich","year":"2017","unstructured":"Nikolich-\u017dugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2017;19:10\u20139.","journal-title":"Nat Immunol"},{"key":"8773_CR49","doi-asserted-by":"crossref","unstructured":"M\u00fcller L, Di Benedetto S. Immunosenescence and cytomegalovirus: exploring their connection in the context of aging, health, and disease. Int J Mol Sci. 2024;25:753.","DOI":"10.3390\/ijms25020753"},{"key":"8773_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","volume":"30","author":"N-P Weng","year":"2009","unstructured":"Weng N-P, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol. 2009;30:306\u201312.","journal-title":"Trends Immunol"},{"key":"8773_CR51","doi-asserted-by":"publisher","first-page":"e1010152","DOI":"10.1371\/journal.ppat.1010152","volume":"17","author":"SPH van den Berg","year":"2021","unstructured":"van den Berg SPH, Derksen LY, Drylewicz J, Nanlohy NM, Beckers L, Lanfermeijer J, et al. Quantification of T-cell dynamics during latent cytomegalovirus infection in humans. PLoS Pathog. 2021;17:e1010152.","journal-title":"PLoS Pathog"},{"key":"8773_CR52","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3389\/fmicb.2016.02111","volume":"7","author":"W Tu","year":"2016","unstructured":"Tu W, Rao S. Mechanisms underlying T cell immunosenescence: aging and cytomegalovirus infection. Front Microbiol. 2016;7:2111.","journal-title":"Front Microbiol"},{"key":"8773_CR53","doi-asserted-by":"crossref","unstructured":"Hassouneh F, Goldeck D, Pera A, van Heemst D, Slagboom PE, Pawelec G, et al. Functional changes of T-cell subsets with age and CMV infection. Int J Mol Sci. 2021;22:9973.","DOI":"10.3390\/ijms22189973"},{"key":"8773_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604591","volume":"11","author":"IJ Rodriguez","year":"2021","unstructured":"Rodriguez IJ, Lalinde Ruiz N, Llano Le\u00f3n M, Mart\u00ednez Enr\u00edquez L, Montilla Vel\u00e1squez MDP, Ortiz Aguirre JP, et al. Immunosenescence study of T cells: a systematic review. Front Immunol. 2021;11:604591.","journal-title":"Front Immunol"},{"key":"8773_CR55","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/eji.201545586","volume":"46","author":"H Tabibian-Keissar","year":"2015","unstructured":"Tabibian-Keissar H, Hazanov L, Schiby G, Rosenthal N, Rakovsky A, Michaeli M, et al. Aging affects B-cell antigen receptor repertoire diversity in primary and secondary lymphoid tissues. Eur J Immunol. 2015;46:480\u201392.","journal-title":"Eur J Immunol"},{"key":"8773_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12979-020-00210-z","volume":"17","author":"D Frasca","year":"2020","unstructured":"Frasca D, Blomberg BB. Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination. Immun Ageing. 2020;17:37.","journal-title":"Immun Ageing"},{"key":"8773_CR57","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.arr.2013.04.003","volume":"12","author":"J Hazeldine","year":"2013","unstructured":"Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev. 2013;12:1069\u201378.","journal-title":"Ageing Res Rev"},{"key":"8773_CR58","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1089\/ars.2021.0056","volume":"35","author":"MS Kingren","year":"2021","unstructured":"Kingren MS, Starr ME, Saito H. Divergent sepsis pathophysiology in older adults. Antioxid Redox Signal. 2021;35:1358\u201375.","journal-title":"Antioxid Redox Signal"},{"key":"8773_CR59","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.4049\/jimmunol.1701618","volume":"200","author":"IJ Jensen","year":"2018","unstructured":"Jensen IJ, Sjaastad FV, Griffith TS, Badovinac VP. Sepsis-induced T cell immunoparalysis: the Ins and Outs of impaired T cell immunity. J Immunol. 2018;200:1543\u201353.","journal-title":"J Immunol"},{"key":"8773_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/cc13941","volume":"18","author":"S Inoue","year":"2014","unstructured":"Inoue S, Suzuki K, Komori Y, Morishita Y, Suzuki-Utsunomiya K, Hozumi K, et al. Persistent inflammation and T cell exhaustion in severe sepsis in the elderly. Crit Care. 2014;18:R130.","journal-title":"Crit Care"},{"key":"8773_CR61","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/SHK.0000000000001352","volume":"53","author":"M Saito","year":"2020","unstructured":"Saito M, Inoue S, Yamashita K, Kakeji Y, Fukumoto T, Kotani J. IL-15 improves aging-induced persistent T cell exhaustion in mouse models of repeated sepsis. Shock. 2020;53:228\u201335.","journal-title":"Shock"},{"key":"8773_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1101918","volume":"14","author":"F Wang","year":"2023","unstructured":"Wang F, Cui Y, He D, Gong L, Liang H. Natural killer cells in sepsis: friends or foes? Front Immunol. 2023;14:1101918.","journal-title":"Front Immunol"},{"key":"8773_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/cc12700","volume":"17","author":"F Souza-Fonseca-Guimaraes","year":"2013","unstructured":"Souza-Fonseca-Guimaraes F, Cavaillon J-M, Adib-Conquy M. Bench-to-bedside review: natural killer cells in sepsis - guilty or not guilty? Crit Care. 2013;17:235.","journal-title":"Crit Care"},{"key":"8773_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01588-z","volume":"15","author":"R Mottale","year":"2025","unstructured":"Mottale R, Dupuis C, Szklarzewska S, Preiser J-C. The metabolic response to stress in critical illness: updated review on the pathophysiological mechanisms, consequences, and therapeutic implications. Ann Intensive Care. 2025;15:174.","journal-title":"Ann Intensive Care"},{"key":"8773_CR65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1474-9726.2012.00839.x","volume":"11","author":"J Hazeldine","year":"2012","unstructured":"Hazeldine J, Hampson P, Lord JM. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell. 2012;11:751\u20139.","journal-title":"Aging Cell"},{"key":"8773_CR66","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.immuni.2017.03.009","volume":"46","author":"TR Kollmann","year":"2017","unstructured":"Kollmann TR, Kampmann B, Mazmanian SK, Marchant A, Levy O. Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity. 2017;46:350\u201363.","journal-title":"Immunity"},{"key":"8773_CR67","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.it.2014.04.007","volume":"35","author":"DJ Dowling","year":"2014","unstructured":"Dowling DJ, Levy O. Ontogeny of early life immunity. Trends Immunol. 2014;35:299\u2013310.","journal-title":"Trends Immunol"},{"key":"8773_CR68","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nri2075","volume":"7","author":"O Levy","year":"2007","unstructured":"Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379\u201390.","journal-title":"Nat Rev Immunol"},{"key":"8773_CR69","doi-asserted-by":"publisher","first-page":"e0162242","DOI":"10.1371\/journal.pone.0162242","volume":"11","author":"SB Prabhu","year":"2016","unstructured":"Prabhu SB, Rathore DK, Nair D, Chaudhary A, Raza S, Kanodia P, et al. Comparison of human neonatal and adult blood leukocyte subset composition phenotypes. PLoS One. 2016;11:e0162242.","journal-title":"PLoS One"},{"key":"8773_CR70","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3389\/fimmu.2014.00393","volume":"5","author":"I Debock","year":"2014","unstructured":"Debock I, Flamand V. Unbalanced neonatal CD4(+) T-cell immunity. Front Immunol. 2014;5:393.","journal-title":"Front Immunol"},{"key":"8773_CR71","doi-asserted-by":"crossref","unstructured":"Nielsen SCA, Roskin KM, Jackson KJL, Joshi SA, Nejad P, Lee J-Y, et al. Shaping of infant B cell receptor repertoires by environmental factors and infectious disease. Sci Transl Med. 2019;11:eaat2004.","DOI":"10.1126\/scitranslmed.aat2004"},{"key":"8773_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cyto.b.21485","volume":"92","author":"DM Strauss-Albee","year":"2016","unstructured":"Strauss-Albee DM, Liang EC, Ranganath T, Aziz N, Blish CA. The newborn human NK cell repertoire is phenotypically formed but functionally reduced. Cytom B Clin Cytom. 2016;92:33\u201341.","journal-title":"Cytom B Clin Cytom"},{"key":"8773_CR73","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3389\/fimmu.2019.01540","volume":"10","author":"M Pyzik","year":"2019","unstructured":"Pyzik M, Sand KMK, Hubbard JJ, Andersen JT, Sandlie I, Blumberg RS. The neonatal Fc receptor (FcRn): a misnomer?. Front Immunol. 2019;10:1540.","journal-title":"Front Immunol"},{"key":"8773_CR74","doi-asserted-by":"publisher","first-page":"12943","DOI":"10.1073\/pnas.2004325117","volume":"117","author":"S Borghi","year":"2020","unstructured":"Borghi S, Bournazos S, Thulin NK, Li C, Gajewski A, Sherwood RW, et al. FcRn, but not Fc\u03b3Rs, drives maternal-fetal transplacental transport of human IgG antibodies. Proc Natl Acad Sci USA 2020;117:12943\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8773_CR75","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abh3816","volume":"7","author":"KZ Sanidad","year":"2022","unstructured":"Sanidad KZ, Amir M, Ananthanarayanan A, Singaraju A, Shiland NB, Hong HS, et al. Maternal gut microbiome-induced IgG regulates neonatal gut microbiome and immunity. Sci Immunol. 2022;7:eabh3816.","journal-title":"Sci Immunol"},{"key":"8773_CR76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/imr.13411","volume":"328","author":"V Verhasselt","year":"2024","unstructured":"Verhasselt V, Tellier J, Carsetti R, Tepekule B. Antibodies in breast milk: pro-bodies designed for healthy newborn development. Immunol Rev. 2024;328:192\u2013204.","journal-title":"Immunol Rev"},{"key":"8773_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.744104","volume":"9","author":"A Camacho-Morales","year":"2021","unstructured":"Camacho-Morales A, Caba M, Garc\u00eda-Ju\u00e1rez M, Caba-Flores MD, Viveros-Contreras R, Mart\u00ednez-Valenzuela C. Breastfeeding contributes to physiological immune programming in the newborn. Front Pediatr. 2021;9:744104.","journal-title":"Front Pediatr"},{"key":"8773_CR78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2421106122","volume":"122","author":"NN Brodsky","year":"2025","unstructured":"Brodsky NN, Chakder M, Kumar DBU, Barmada A, Wang J, Gu W, et al. Early-life human CD8+ T cells exhibit rapid, short-lived effector responses and a unique transcription factor landscape. Proc Natl Acad Sci USA 2025;122:e2421106122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8773_CR79","doi-asserted-by":"crossref","unstructured":"Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020;21:e52\u2013e106.","DOI":"10.1097\/PCC.0000000000002444"},{"key":"8773_CR80","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1542\/peds.2021-052888N","volume":"149","author":"MW Hall","year":"2022","unstructured":"Hall MW, Carcillo JA, Cornell T. Immune system dysfunction criteria in critically ill children: the PODIUM consensus conference. Pediatrics. 2022;149:S91\u2013S8.","journal-title":"Pediatrics"},{"key":"8773_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/cc13980","volume":"18","author":"JA Muszynski","year":"2014","unstructured":"Muszynski JA, Nofziger R, Greathouse K, Steele L, Hanson-Huber L, Nateri J, et al. Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care. 2014;18:R145.","journal-title":"Crit Care"},{"key":"8773_CR82","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201710-2006OC","volume":"198","author":"JA Muszynski","year":"2018","unstructured":"Muszynski JA, Nofziger R, Moore-Clingenpeel M, Greathouse K, Anglim L, Steele L, et al. Early immune function and duration of organ dysfunction in critically iii children with sepsis. Am J Respir Crit Care Med. 2018;198:361\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"8773_CR83","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1097\/CCM.0000000000005993","volume":"51","author":"BS Podd","year":"2023","unstructured":"Podd BS, Banks RK, Reeder R, Telford R, Holubkov R, Carcillo J, et al. Early, persistent lymphopenia is associated with prolonged multiple organ failure and mortality in septic children. Crit Care Med. 2023;51:1766\u201376.","journal-title":"Crit Care Med"},{"key":"8773_CR84","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/SHK.0000000000001943","volume":"57","author":"RB Lindell","year":"2022","unstructured":"Lindell RB, Zhang D, Bush J, Wallace DC, Rabinowitz JD, Lu W, et al. Impaired lymphocyte responses in pediatric sepsis vary by pathogen type and are associated with features of immunometabolic dysregulation. Shock. 2022;57:191\u20139.","journal-title":"Shock"},{"key":"8773_CR85","doi-asserted-by":"crossref","unstructured":"Akhmaltdinova LL, Zhumadilova ZA, Kolesnichenko SI, Lavrinenko AV, Kadyrova IA, Avdienko OV, et al. The presence of PDL-1 on CD8+ lymphocytes is linked to survival in neonatal sepsis. Children. 2022;9:1171.","DOI":"10.3390\/children9081171"},{"key":"8773_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940930","volume":"13","author":"E Hensler","year":"2022","unstructured":"Hensler E, Petros H, Gray CC, Chung C-S, Ayala A, Fallon EA. The neonatal innate immune response to sepsis: checkpoint proteins as novel mediators of this response and as possible therapeutic\/diagnostic levers. Front Immunol. 2022;13:940930.","journal-title":"Front Immunol"},{"key":"8773_CR87","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/01.qco.0000224821.27482.bd","volume":"19","author":"S Kenzel","year":"2006","unstructured":"Kenzel S, Henneke P. The innate immune system and its relevance to neonatal sepsis. Curr Opin Infect Dis. 2006;19:264\u201370.","journal-title":"Curr Opin Infect Dis"},{"key":"8773_CR88","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1097\/CCM.0000000000002932","volume":"46","author":"HR Wong","year":"2018","unstructured":"Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. Endotype transitions during the acute phase of pediatric septic shock reflect changing risk and treatment response. Crit Care Med. 2018;46:e242\u2013e9.","journal-title":"Crit Care Med"},{"key":"8773_CR89","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S2352-4642(24)00141-X","volume":"8","author":"MJ Carter","year":"2024","unstructured":"Carter MJ, Carrol ED, Ranjit S, Mozun R, Kissoon N, Watson RS, et al. Susceptibility to childhood sepsis, contemporary management, and future directions. Lancet Child Adolesc Health. 2024;8:682\u201394.","journal-title":"Lancet Child Adolesc Health"},{"key":"8773_CR90","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.chest.2023.05.002","volume":"164","author":"SG Patterson","year":"2023","unstructured":"Patterson SG, Lamb CK, Gong W, Resser J, Lindsell CJ, Van Driest SL, et al. Pediatric persistent inflammation, immunosuppression, and catabolism syndrome prevalence in sepsis-related mortalities: a 23-year institutional history. Chest. 2023;164:1204\u201315.","journal-title":"Chest"},{"key":"8773_CR91","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/0115733963298459240508050319","volume":"21","author":"MD Santarelli","year":"2025","unstructured":"Santarelli MD, Davis KA, Stark RJ. Persistent inflammation, immunosuppression and catabolism syndrome in pediatric populations: a brief perspective. Curr Pediatr Rev. 2025;21:297\u2013300.","journal-title":"Curr Pediatr Rev"},{"key":"8773_CR92","unstructured":"Bembea MM, Agus M, Akcan-Arikan A, Alexander P, Basu R, Bennett TD, et al. Pediatric organ dysfunction information update mandate (PODIUM) contemporary organ dysfunction criteria: executive summary. Pediatrics. 2022;149:S1\u2013S12."},{"key":"8773_CR93","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"8773_CR94","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41577-019-0180-1","volume":"19","author":"JJ Goronzy","year":"2019","unstructured":"Goronzy JJ, Weyand CM. Mechanisms underlying T cell ageing. Nat Rev Immunol. 2019;19:573\u201383.","journal-title":"Nat Rev Immunol"},{"key":"8773_CR95","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri.2017.54","volume":"17","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhivaki D, Lo-Man R. Unique aspects of the perinatal immune system. Nat Rev Immunol. 2017;17:495\u2013507.","journal-title":"Nat Rev Immunol"},{"key":"8773_CR96","doi-asserted-by":"crossref","unstructured":"Sun X, Nguyen T, Achour A, Ko A, Cifello J, Ling C, et al. Longitudinal analysis reveals age-related changes in the T cell receptor repertoire of human T cell subsets. J Clin Invest. 2022;132:e158122.","DOI":"10.1172\/JCI158122"},{"key":"8773_CR97","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1302064","volume":"192","author":"OV Britanova","year":"2014","unstructured":"Britanova OV, Putintseva EV, Shugay M, Merzlyak EM, Turchaninova MA, Staroverov DB, et al. Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J Immunol. 2014;192:2689\u201398.","journal-title":"J Immunol"},{"key":"8773_CR98","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.exger.2014.03.020","volume":"55","author":"P Sansoni","year":"2014","unstructured":"Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu Y-L, et al. New advances in CMV and immunosenescence. Exp Gerontol. 2014;55:54\u201362.","journal-title":"Exp Gerontol"},{"key":"8773_CR99","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.celrep.2016.10.056","volume":"17","author":"AO Galindo-Albarr\u00e1n","year":"2016","unstructured":"Galindo-Albarr\u00e1n AO, L\u00f3pez-Portales OH, Guti\u00e9rrez-Reyna DY, Rodr\u00edguez-Jorge O, S\u00e1nchez-Villanueva JA, Ram\u00edrez-Pliego O, et al. CD8+ T cells from human neonates are biased toward an innate immune response. Cell Rep. 2016;17:2151\u201360.","journal-title":"Cell Rep"},{"key":"8773_CR100","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","volume":"37","author":"MW Hall","year":"2010","unstructured":"Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2010;37:525\u201332.","journal-title":"Intensive Care Med"},{"key":"8773_CR101","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/TA.0b013e318256e000","volume":"72","author":"LF Gentile","year":"2012","unstructured":"Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72:1491\u2013501.","journal-title":"J Trauma Acute Care Surg"},{"key":"8773_CR102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ccc.2016.12.001","volume":"33","author":"JC Mira","year":"2017","unstructured":"Mira JC, Brakenridge SC, Moldawer LL, Moore FA. Persistent inflammation, immunosuppression and catabolism syndrome. Crit Care Clin. 2017;33:245\u201358.","journal-title":"Crit Care Clin"},{"key":"8773_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-34","volume":"7","author":"HR Wong","year":"2009","unstructured":"Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Willson DF, et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med. 2009;7:34.","journal-title":"BMC Med"},{"key":"8773_CR104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25:19\u201328.","journal-title":"Nat Immunol"},{"key":"8773_CR105","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/s41591-025-03956-5","volume":"31","author":"AR Moore","year":"2025","unstructured":"Moore AR, Zheng H, Ganesan A, Hasin-Brumshtein Y, Maddali MV, Levitt JE, et al. A consensus immune dysregulation framework for sepsis and critical illnesses. Nat Med. 2025;31:4084\u201396.","journal-title":"Nat Med"},{"key":"8773_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05684-1","volume":"29","author":"LR Van Nynatten","year":"2025","unstructured":"Van Nynatten LR, Bokhary D, Wong MYS, Wang J, Fero H, McChesney C, et al. Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review. Crit Care. 2025;29:504.","journal-title":"Crit Care"},{"key":"8773_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0242-0","volume":"7","author":"C Adrie","year":"2017","unstructured":"Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier J-C, et al. Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann Intensive Care. 2017;7:30.","journal-title":"Ann Intensive Care"},{"key":"8773_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2830-x","volume":"24","author":"GP Leijte","year":"2020","unstructured":"Leijte GP, Rimmel\u00e9 T, Kox M, Bruse N, Monard C, Gossez M, et al. Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes. Crit Care. 2020;24:110.","journal-title":"Crit Care"},{"key":"8773_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-022-01010-y","volume":"12","author":"C de Roquetaillade","year":"2022","unstructured":"de Roquetaillade C, Dupuis C, Faivre V, Lukaszewicz AC, Brumpt C, Payen D. Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: relation with secondary infections. Ann Intensive Care. 2022;12:39.","journal-title":"Ann Intensive Care"},{"key":"8773_CR110","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cyto.b.21987","volume":"100","author":"KJ Quadrini","year":"2021","unstructured":"Quadrini KJ, Patti-Diaz L, Maghsoudlou J, Cuomo J, Hedrick MN, McCloskey TW. A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials. Cytom B Clin Cytom. 2021;100:103\u201314.","journal-title":"Cytom B Clin Cytom"},{"key":"8773_CR111","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.pcl.2017.06.008","volume":"64","author":"MW Hall","year":"2017","unstructured":"Hall MW, Greathouse KC, Thakkar RK, Sribnick EA, Muszynski JA. Immunoparalysis in pediatric critical care. Pediatr Clin North Am. 2017;64:1089\u2013102.","journal-title":"Pediatr Clin North Am"},{"key":"8773_CR112","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009;180:640\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"8773_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154330","volume":"78","author":"C-H Vacheron","year":"2023","unstructured":"Vacheron C-H, Lepape A, Venet F, Monneret G, Gueyffier F, Boutitie F, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: the GRID randomized controlled trial. J Crit Care. 2023;78:154330.","journal-title":"J Crit Care"},{"key":"8773_CR114","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.aucc.2023.04.002","volume":"37","author":"J Minogue","year":"2023","unstructured":"Minogue J, Keogh S, Schlapbach LJ, Long D. Long-term outcomes after paediatric sepsis: a narrative review. Aust Crit Care. 2023;37:499\u2013507.","journal-title":"Aust Crit Care"},{"key":"8773_CR115","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2024.0179","volume":"331","author":"LJ Schlapbach","year":"2024","unstructured":"Schlapbach LJ, Watson RS, Sorce LR, Argent AC, Menon K, Hall MW, et al. International consensus criteria for pediatric sepsis and septic shock. JAMA. 2024;331:665\u201374.","journal-title":"JAMA"},{"key":"8773_CR116","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1213\/ANE.0000000000004665","volume":"130","author":"JC De Biasio","year":"2020","unstructured":"De Biasio JC, Mittel AM, Mueller AL, Ferrante LE, Kim DH, Shaefi S. Frailty in critical care medicine: a review. Anesth Analg. 2020;130:1462\u201373.","journal-title":"Anesth Analg"},{"key":"8773_CR117","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00134-017-4867-0","volume":"43","author":"J Muscedere","year":"2017","unstructured":"Muscedere J, Waters B, Varambally A, Bagshaw SM, Boyd JG, Maslove D, et al. The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med. 2017;43:1105\u201322.","journal-title":"Intensive Care Med"},{"key":"8773_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01132-x","volume":"13","author":"RR Bruno","year":"2023","unstructured":"Bruno RR, Wernly B, Bagshaw SM, van den Boogaard M, Darvall JN, De Geer L, et al. The Clinical Frailty Scale for mortality prediction of old acutely admitted intensive care patients: a meta-analysis of individual patient-level data. Ann Intensive Care. 2023;13:37.","journal-title":"Ann Intensive Care"},{"key":"8773_CR119","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2017.17687","volume":"319","author":"HC Prescott","year":"2018","unstructured":"Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA. 2018;319:62\u201375.","journal-title":"JAMA"},{"key":"8773_CR120","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S2352-4642(24)00140-8","volume":"8","author":"RS Watson","year":"2024","unstructured":"Watson RS, Carrol ED, Carter MJ, Kissoon N, Ranjit S, Schlapbach LJ. The burden and contemporary epidemiology of sepsis in children. Lancet Child Adolesc Health. 2024;8:670\u201381.","journal-title":"Lancet Child Adolesc Health"},{"key":"8773_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104363","volume":"86","author":"WJ Wiersinga","year":"2022","unstructured":"Wiersinga WJ, van der Poll T. Immunopathophysiology of human sepsis. EBioMedicine. 2022;86:104363.","journal-title":"EBioMedicine"},{"key":"8773_CR122","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang S-Y, Sun J-H, Zhang H-C, Cai Q-L, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9:56.","journal-title":"Mil Med Res"},{"key":"8773_CR123","doi-asserted-by":"publisher","first-page":"e1289","DOI":"10.1097\/CCM.0000000000002733","volume":"45","author":"HR Wong","year":"2017","unstructured":"Wong HR, Sweeney TE, Hart KW, Khatri P, Lindsell CJ. Pediatric sepsis endotypes among adults with sepsis. Crit Care Med. 2017;45:e1289\u2013e91.","journal-title":"Crit Care Med"},{"key":"8773_CR124","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/cyto.b.22133","volume":"104","author":"M Haem Rahimi","year":"2023","unstructured":"Haem Rahimi M, Conti F, Llitjos J-F, Fleurie A, Cerro V, Venet F, et al. Monocyte HLA-DR expression as an enrollment biomarker in sepsis clinical trials: evaluation of two sampling tubes and definition of respective clinical thresholds. Cytom B Clin Cytom. 2023;104:468\u201370.","journal-title":"Cytom B Clin Cytom"},{"key":"8773_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04964-6","volume":"28","author":"MA Slim","year":"2024","unstructured":"Slim MA, van Mourik N, Bakkerus L, Fuller K, Acharya L, Giannidis T, et al. Towards personalized medicine: a scoping review of immunotherapy in sepsis. Crit Care. 2024;28:183.","journal-title":"Crit Care"},{"key":"8773_CR126","doi-asserted-by":"publisher","first-page":"e2044","DOI":"10.1097\/MD.0000000000002044","volume":"94","author":"B Mathias","year":"2015","unstructured":"Mathias B, Szpila BE, Moore FA, Efron PA, Moldawer LL. A review of GM-CSF therapy in sepsis. Medicine. 2015;94:e2044.","journal-title":"Medicine"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08773-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:02:35Z","timestamp":1782180155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08773-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8773"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08773-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"595"}}